INVIMA Approved Oncology
Product Description
Lodaat Pharma
-
US
-
2015On CPHI since
-
4Certificates
-
100 - 249Employees
Company types
Primary activities
Categories
Specifications
Lodaat Pharma
-
US
-
2015On CPHI since
-
4Certificates
-
100 - 249Employees
Company types
Primary activities
More Products from Lodaat Pharma (5)
-
Product RARE DISEASES & ORPHAN DRUGS
Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products. USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets. Many products are made in USA products in FDA approved facilities. -
Product Biosimilars, and High Value Molecules
Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules. We are looking for reputable global partners who want to expand their product line and in-license for their territory. -
Product USFDA Oral Solid Dosages
USFDA Oral Solid Dosages in major Therapeutic categories. All products are USFDA registered and available in either Zone II or Zone IV stability studies. Full dossiers available in either ECTD or CTD formats -
Product EU GMP Oral Solid Dosage List
LODAAT's Oral Solid Dosages are EU-GMP facility approved and are available in innovations such as ODT, Sachets, and Extended Release. Our facilities handle all testing, production and full packaging capabilities. -
Product Vitamins & OTC products- USA made
LODAAT produces the best quality USA made Vitamins, Herbal supplements, Minerals and OTC products. Our finished formulations are available in Tablets and Capsules. We have 3 US facilities producing Private Label and Branded goods in Bottles and Blister packaging. Best selling products inc...
Lodaat Pharma resources (4)
-
News CPHI Milan Speaker Spotlight: The microbiome and investing in future therapies
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conference. -
Video Lodaat Introduction
This video provides an Introduction to the LODAAT team, product categories, facilities, research and innovation. -
News CPHI Barcelona Speaker Interview: Rare diseases and the microbiome boom
At CPHI Barcelona (24–26 October, 2023) we took the time to catch up with one of our speakers, Rajiv Khatau who gave a presentation on: The Microbiome Boom - Unlocking Potential Through Listening to the Gut and was a panellist on: Why Building a Collaborative Network is Essential for Rare Disease Therapies. -
News CHEMISTRY TODAY- Citizen Doctor-April 2019
CITIZEN DOCTOR: PERSONALIZED MEDICINEFOR INGREDIENT INDUSTRY- How Personalized medicine can be implemented
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance